# Pilot Study of Growth Hormon to Treat SMA Typ II and III

> **NCT00533221** · PHASE2 · COMPLETED · sponsor: **University Hospital Freiburg** · enrollment: 20 (actual)

## Conditions studied

- Muscular Atrophy, Spinal

## Interventions

- **DRUG:** somatotropin
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00533221
- **Lead sponsor:** University Hospital Freiburg
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-10
- **Primary completion:** 2010-02
- **Final completion:** 2011-08
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2013-12-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00533221

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00533221, "Pilot Study of Growth Hormon to Treat SMA Typ II and III". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00533221. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*